Copresentation of Tumor Antigens and Costimulatory Molecules via Biomimetic Nanoparticles for Effective Cancer Immunotherapy
Source abstract
Abstract
Nanoparticle (NP)-based cancer immunotherapy has been extensively explored. However, the efficacy of existing strategies is often limited by the lack of effective tumor-specific antigens or the inability to present costimulatory signal or both. Here, we report a novel approach to overcoming these limitations through surface coating with dendritic-tumor fusion cell membranes, which present whole repertories of tumor-associated antigens in the presence of costimulatory molecules. Because antigen-presenting and costimulatory molecules are displayed on their surface, these NPs can efficiently penetrate immune organs and activate T cells. We show that these NPs can be utilized to prevent tumor development and regress established tumors, including tumors in the brain. We demonstrate that encapsulation of immune adjuvants further improves their efficacy. Due to their significant efficacy, the whole tumor antigen-presenting costimulatory NPs have the potential to be translated into clinical applications for treatment of various cancers.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Immunotherapy and Immune Responses · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Neurosurgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong 510080, China
Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045, United States
Funding
National Institute of Neurological Disorders and Stroke · State of Connecticut
References (43)
Show source-provided references
1. 10.1016/S1470-2045(13)70585-010.1016/S1470-2045(13)70585-0 ↗
2. 10.1158/1078-0432.CCR-15-139910.1158/1078-0432.CCR-15-1399 ↗
3. 10.1586/14760584.7.10.153310.1586/14760584.7.10.1533 ↗
4. 10.1038/nm0303-26910.1038/nm0303-269 ↗
5. 10.3390/ijms1706082810.3390/ijms17060828 ↗
6. 10.2217/imt.15.7310.2217/imt.15.73 ↗
7. 10.1038/nm0597-55810.1038/nm0597-558 ↗
8. 10.1038/7319310.1038/73193 ↗
9. 10.1097/00002371-200411000-0000510.1097/00002371-200411000-00005 ↗
10. 10.1016/j.vaccine.2005.01.08110.1016/j.vaccine.2005.01.081 ↗
11. 10.3109/14653249.2011.55359310.3109/14653249.2011.553593 ↗
12. 10.1007/s00262010020510.1007/s002620100205 ↗
13. 10.1097/00002371-200411000-0000510.1097/00002371-200411000-00005 ↗
14. 10.4049/jimmunol.181.1.80810.4049/jimmunol.181.1.808 ↗
15. 10.1038/sj.gt.330049610.1038/sj.gt.3300496 ↗
16. 10.1002/smll.20190201110.1002/smll.201902011 ↗
17. 10.1038/nmat482210.1038/nmat4822 ↗
18. 10.1038/nature1400110.1038/nature14001 ↗
19. 10.1038/s41598-018-30510-w10.1038/s41598-018-30510-w ↗
20. 10.1016/j.nano.2016.03.00510.1016/j.nano.2016.03.005 ↗
21. 10.1016/j.biomaterials.2011.09.06110.1016/j.biomaterials.2011.09.061 ↗
22. 10.1038/s41590-019-0433-y10.1038/s41590-019-0433-y ↗
23. 10.1021/acsami.9b1838810.1021/acsami.9b18388 ↗
24. 10.1021/acs.nanolett.9b0381710.1021/acs.nanolett.9b03817 ↗
25. 10.1016/j.jconrel.2012.01.04310.1016/j.jconrel.2012.01.043 ↗
26. 10.1073/pnas.130450411010.1073/pnas.1304504110 ↗
27. 10.1038/nnano.2017.5210.1038/nnano.2017.52 ↗
28. 10.1038/nm.219810.1038/nm.2198 ↗
29. 10.1038/nnano.2017.5710.1038/nnano.2017.57 ↗
30. 10.1016/j.molimm.2018.02.01610.1016/j.molimm.2018.02.016 ↗
31. 10.1016/j.it.2017.05.00610.1016/j.it.2017.05.006 ↗
32. 10.1021/nl500618u10.1021/nl500618u ↗
33. 10.1021/acsnano.7b0253310.1021/acsnano.7b02533 ↗
34. 10.1021/acsnano.7b0904110.1021/acsnano.7b09041 ↗
35. 10.1016/S0022-1759(98)00204-X10.1016/S0022-1759(98)00204-X ↗
36. 10.1073/pnas.110663410810.1073/pnas.1106634108 ↗
37. 10.1007/s11060-014-1658-010.1007/s11060-014-1658-0 ↗
38. 10.1021/acsnano.5b0757310.1021/acsnano.5b07573 ↗
39. 10.3791/5277110.3791/52771 ↗
40. 10.1016/j.jconrel.2015.04.01010.1016/j.jconrel.2015.04.010 ↗
41. 10.1038/nmat296010.1038/nmat2960 ↗
42. 10.1038/nature1442410.1038/nature14424 ↗
43. 10.1016/S1046-2023(02)00348-110.1016/S1046-2023(02)00348-1 ↗